Two of these mutations were ever present on FFPE matched samples (SSM #12 and nodular #9 melanoma), they were detected retrospectively with the Sanger sequencing method, and one BRAF L597S mutation appeared de novo in an acral lentiginous melanoma after stabilization on immunotherapy (#1). This evidence concerns the gene BRAF and acral lentiginous melanoma.